Accuracy of ICG compared with technetium-99 m for sentinel lymph node biopsy in vulvar cancer.

ICG Sentinel lymph node biopsy Technetium Vulvar cancer

Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
03 Jan 2024
Historique:
received: 18 05 2023
revised: 08 11 2023
accepted: 27 12 2023
medline: 7 1 2024
pubmed: 7 1 2024
entrez: 6 1 2024
Statut: aheadofprint

Résumé

Sentinel lymph node biopsy with radioactive tracer is the standard-of-care in lymph node status assessment in vulvar cancer. Indocyanine green fluorescence-ICG is a promising detection method, due to its advantages over technetium-99 m. In vulvar cancer, the procedure is controversial due to study heterogeneity and the small sample size in previous studies. This study evaluates ICG sentinel lymph node detection compared with the criterion-standard with technetium (dual modality method). Preoperative technetium and intraoperative ICG for sentinel lymph node have been prospectively evaluated in early-stage vulvar cancer. The primary endpoint was to determine accuracy in the detection rate for ICG compared with technetium. Secondary objectives included tracer modality relationship with obesity, tumor size and location. In total, 75 patients participated at 8 centers; 38 had lateral and 37 had midline vulvar tumors. The overall sentinel lymph node detection rate was 85.3 % for technetium and 82.7 % for ICG. For lateral tumors, the detection rate was 84.2 % vs. 89.5 %, while it was 86.5 % vs. 75.7 % for middle tumors, using technetium and ICG, respectively. The median sentinel node harvest was 1.7 (range 1-4), with 24 % metastatic involvement. The sensitivity and positive predictive value for ICG based on the standard technique with technetium was 91.08 % (95 % CI, 83.76-95.84) and 94.8 % (95 % CI, 84.84-96.48), respectively. No significant differences were found comparing the two tracers in patients with midline lesions, obesity (body mass index ≥ 30) and tumor size ≥ 2-4 cm. ICG shows comparable performance parameters to the gold-standard of radioisotope localization.

Identifiants

pubmed: 38183845
pii: S0301-2115(23)00887-4
doi: 10.1016/j.ejogrb.2023.12.037
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-19

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Alberto Rafael Guijarro-Campillo (AR)

Department of Gynecologic Oncology, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain. Electronic address: alguicam@alumni.uv.es.

Pablo Padilla-Iserte (P)

Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital, Valencia, Spain.

Bárbara Couso (B)

Department of Obstetrics and Gynecology, University Hospital of Ourense, Spain.

Diego Erasun (D)

Department of Obstetrics and Gynecology, Hospital Marqués de Valdecilla, Santander, Spain.

Jesús Utrilla-Layna (J)

Department of Gynecological Oncology Fundación Jiménez Díaz, Madrid, Spain.

Octavio Arencibia (O)

Department of Gynecologic Oncology, Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas de Gran Canaria, Spain.

Ana Boldo-Roda (A)

Department of Obstetrics and Gynecology, University Hospital La Plana, Villareal, Spain.

Juan Gilabert-Estellés (J)

Department of Obstetrics and Gynecology, University General Hospital of Valencia, University of Valencia, Spain.

Nadia Veiga (N)

Department of Gynecologic Oncology, Complejo Hospitalario de Navarra, Spain.

Víctor Lago (V)

Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital, Valencia, Spain.

José Miguel Cárdenas-Rebollo (JM)

Department of Applied Mathematics and Statistics, CEU San Pablo University, Madrid, Spain.

Santiago Domingo (S)

Department of Gynecologic Oncology, La Fe University and Polytechnic Hospital, Valencia, Spain.

Classifications MeSH